With a new DARPA contract, biological engineer Christopher Voigt aims to harness the power of living cells.

Researchers find pathway that controls metabolism by prompting fat cells to store or burn fat.

Engineered particles are capable of producing toxins that are deadly to targeted bacteria.

Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease.

11 MIT affiliates and more than 30 alumni are identified as movers, makers, and game changers in their respective fields.